InMed Pharmaceuticals
11 hedge funds and large institutions have $109K invested in InMed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
53% less capital invested
Capital invested by funds: $234K → $109K (-$125K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$84K | |
| 2 | +$20.3K | |
| 3 | +$1.97K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.92K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$13 |
Top Sellers
| 1 | -$196K | |
| 2 | -$36K | |
| 3 | -$43 | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$12 |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$10 |